An independent sponsor focused on the lower middle market

Since 2003, the Essex Partners (“EP”) principals have provided operational and financial support to lower middle market companies across a broad range of industries. EP was formed to invest in companies with defensible market positions, significant growth opportunities and sustainable competitive advantages.

Transaction Types

  • Majority Buyouts

  • Management Buyouts

  • Growth Equity Capital

  • Generational Transitions of Family Owned Businesses

Essex Partners Completes Acquisition of ScarMD and Hematix for Platform Company SkinGenuity

Essex Partners, LLC, an independent sponsor and affiliate of Essex Capital Group, Inc., announced that it recently closed an add-on acquisition of a skincare product line that includes established, best-in-class scar (ScarMD) and bruise (Hematix) treatments. The acquisition will further diversify the product offering for Essex’s existing platform company, SkinGenuity, LLC.

 

United States

Investment Criteria

Financial

Revenues of $5 -$50 million; EBITDA margins of 10% or greater

Structure

Equity and mezzanine debt

Geography

United States

Ownership

Majority or minority equity participation

Investment Amounts

Typically, $2 -$20 million with capacity to finance larger investments

Industry Focus

  • Healthcare

  • Business Services

  • Distribution

  • Retail / Franchise Related

  • Manufacturing